Roivant Sciences Ltd. (Nasdaq: ROIV) is a commercial-stage biopharmaceutical holding company that accelerates the development and commercialization of medicines through its distinctive "Vant" model, a network of nimble, focused subsidiary companies such as Immunovant, Priovant, and Pulmovant. - View it on GitHub